New posts

Reply to thread

Message

Prescient Therapeutics (ASX-PTX)
Live Investor Briefing

Thursday, 12th November 11am (AEDT)

Please join Prescient Therapeutics CEO Steven Yatomi-Clarke for a special live investor briefing.

Event Details:
Date: Thursday, 12th November
Time: 11am (AEDT)

In the session, Steven will discuss:
The company’s promising pipeline of cancer treatments with two targeted therapies, cell therapy enhancements and CAR-T
Its work in the most exciting area of cancer research “next gen” CAR-T and its OmniCAR platform
A strong balance sheet with $20m in the bank following oversubscribed Share Purchase Plan and Placement
This is a live and interactive session, you simply need an internet connection to participate. Don’t miss out, spots are limited – This is a FREE event.

Book your spot here: https://reachmarkets.com.au/live-investor-briefing-ptx/

<blockquote data-quote="System" data-source="post: 1100470" data-attributes="member: 36329">Prescient Therapeutics (ASX-PTX)Live Investor BriefingThursday, 12th November 11am (AEDT)Please join Prescient Therapeutics CEO Steven Yatomi-Clarke for a special live investor briefing.Event Details:Date: Thursday, 12th NovemberTime: 11am (AEDT)In the session, Steven will discuss:<ul>
<li data-xf-list-type="ul">The company’s promising pipeline of cancer treatments with two targeted therapies, cell therapy enhancements and CAR-T</li>
<li data-xf-list-type="ul">Its work in the most exciting area of cancer research “next gen” CAR-T and its OmniCAR platform</li>
<li data-xf-list-type="ul">A strong balance sheet with $20m in the bank following oversubscribed Share Purchase Plan and Placement</li>
</ul>This is a live and interactive session, you simply need an internet connection to participate. Don’t miss out, spots are limited – This is a FREE event.Book your spot here: <a href="https://reachmarkets.com.au/live-investor-briefing-ptx/" target="_blank">https://reachmarkets.com.au/live-investor-briefing-ptx/</a></blockquote>

[QUOTE="System, post: 1100470, member: 36329"] [SIZE=5][B]Prescient Therapeutics (ASX-PTX) Live Investor Briefing Thursday, 12th November 11am (AEDT)[/B][/SIZE] Please join Prescient Therapeutics CEO Steven Yatomi-Clarke for a special live investor briefing. [B]Event Details: Date:[/B] Thursday, 12th November [B]Time:[/B] 11am (AEDT) In the session, Steven will discuss: [LIST] [*]The company’s promising pipeline of cancer treatments with two targeted therapies, cell therapy enhancements and CAR-T [*]Its work in the most exciting area of cancer research “next gen” CAR-T and its OmniCAR platform [*]A strong balance sheet with $20m in the bank following oversubscribed Share Purchase Plan and Placement [/LIST] This is a live and interactive session, you simply need an internet connection to participate. Don’t miss out, spots are limited – This is a FREE event. Book your spot here: [URL]https://reachmarkets.com.au/live-investor-briefing-ptx/[/URL] [/QUOTE]

Verification